Saturday, 24 October, 2020, 8:54 AM
latest
Home International

Endo starts manufacturing Novavax's potential COVID-19 vaccine

Published : Friday, 25 September, 2020 at 5:50 PM  Count : 222
Observer Online News Desk

A doctor lifts a vial with a potential coronavirus, COVID-19, vaccine at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19.(File/AFP)

A doctor lifts a vial with a potential coronavirus, COVID-19, vaccine at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19.(File/AFP)



Generic drugmaker Endo said on Friday it was manufacturing Novavax Inc's experimental COVID-19 vaccine, sending its shares up 10% before the trading bell, reports Reuters.

The news comes a day after Novavax launched a late-stage trial of the vaccine candidate, NVX-CoV2373, in the United Kingdom.

Endo said it has signed a deal with Novavax and its unit Par Sterile has begun production of the final drug product, with initial batches to be used in Novavax’s phase-3 clinical trial in the United States.

Financials and other terms of the non-exclusive agreement were not disclosed.

NVX-CoV2373 is currently also being tested in two ongoing mid-stage trials that began in August.

SZA




















Related Topics

Endo   Novavax   COVID19 vaccine  




« PreviousNext »



Latest News
Most Read News
Editor : Iqbal Sobhan Chowdhury
Published by the Editor on behalf of the Observer Ltd. from Globe Printers, 24/A, New Eskaton Road, Ramna, Dhaka.
Editorial, News and Commercial Offices : Aziz Bhaban (2nd floor), 93, Motijheel C/A, Dhaka-1000. Phone: PABX 9586651-58; Online: 9513959; Advertisement: 9513663
E-mail: [email protected], [email protected], [email protected], [email protected],   [ABOUT US]     [CONTACT US]   [AD RATE]   Developed & Maintenance by i2soft